Ophthalmology group challenges payers recommending biosimilars for eye disease treatment
The request comes in the wake of a supply shortage of Avastin, a drug used to treat vision-threatening diseases like macular degeneration and … Read more
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed